助手标题
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
共[15]条 当前为第1条到15条
 

相关语句
superficial bladder cancer
    LARGE DOSE OF MITOMYCIN c INTRAVESICAL INSTILLATION INTHE PREVENTION OF SUPERFICIAL BLADDER CANCER RECURRENCE
    大剂量丝裂霉素C膀胱灌注预防浅表膀胱癌复发的研究
    The role of cell adhesion, multidrug resistance and cell proliferation in short-term recurrent cases with T_1G_3 superficial bladder cancer
    细胞黏附、多药耐药及细胞增殖在T_1G_3型浅表膀胱癌近期复发中的作用
    Long-term Prognostic Value of the First Recurrence-free Period in Patients with Superficial Bladder Cancer
    首次无复发间期在浅表膀胱癌患者中的远期预后价值
    Conclusions Minimum adhesion, strong drug resistance and maximum proliferation are the main factors that promote short-term recurrence of superficial bladder cancer and also the inherent reasons for easy recurrence and high malignancy of T 1G 3 tumors.
    结论 黏附性低、耐药性强和增殖旺盛是促使T1G3 型浅表膀胱癌近期复发的主要因素 ,同时也是导致T1G3 肿瘤易复发、高恶性度的内在原因。
    ObjectiveTo evaluate the long-term prognostic value of the first recurrence-free period (RFP) in patients with superficial bladder cancer (SBC).
    【目的】评价首次无复发间期 (recurrence freeperiod ,RFP)在浅表膀胱癌患者中的远期预后价值。
    Intravesical Instillation of Pirarubicin (THP) Together with Polyvinylpyrrolidone (PVP) in the Prevention of Postoperative Recurrence of Superficial Bladder Cancer
    吡柔比星联合聚维酮膀胱灌注预防浅表膀胱癌复发
    Immunological effect of intravesical perfusion of polyvinylpyrrolidone (PVP) together with pirarubicin (THP) in the prevention of postoperative recurrence of superficial bladder cancer
    聚维酮在浅表膀胱癌联合灌注化疗中的免疫效果
    Intravesical instillation of polyvinyllpyrrolidone(PVP)combined with pirarubicin(THP)in prevention of postoperative recurrence of superficial bladder cancer
    聚维酮联合吡柔比星膀胱灌注预防浅表膀胱癌复发的初步研究
    Istillation of pirarubicin(THP) combined with IL-2 in prevention of postoperative recurrence of superficial bladder cancer
    吡柔比星联合白细胞介素Ⅱ膀胱灌注预防浅表膀胱癌复发的初步研究
    In order to prevent the relapse of bladder neoplasms,this study was designed to explore the effect of intravesical instillation of pirarubicin(THP) together with polyvinylpyrro lidone (PVP) on patients with superficial bladder cancer who had undergone surgical operation.
    如何预防其复发一直为学者们所关注,本研究探讨吡柔比星(pirarubicin,THP)联合聚维酮(polyvinylpyrrolidone,PVP)膀胱灌注预防浅表膀胱癌复发的疗效及副作用。
    Objective To evaluate the roles of cell adhesion,multidrug resistance and cell proliferation in short-term recurrent cases with superficial bladder cancer, and the prognostic value of the three indexes.
    目的 研究细胞黏附、多药耐药及细胞增殖在浅表膀胱癌近期复发中的作用 ,探讨三者的临床预测价值。
    Methods Fifty-two patients with superficial bladder cancer received intravesical instillation before and after tumor resection.
    方法选择52例浅表膀胱癌患者,采用术前24~48h及术后膀胱灌注。
    Objective:To explore the anti-tumor immunology of intravesical perfusion of polyvinylpyrrolidone together with pirarubicin (PVP/THP) to prevent the recurrence of the superficial bladder cancer.
    目的 :探讨聚维酮联合吡柔比星膀胱灌注预防浅表膀胱癌复发的抗肿瘤免疫效果。
    Objective To evaluate the early efficacy of instillation of pirarubicin(THP) combined with IL-2 in prevention of postoperative recurrence of superficial bladder cancer.
    目的探讨吡柔比星(THP)联合白细胞介素Ⅱ(IL-2)预防浅表膀胱癌术后复发的近期疗效。
    Conclusion Intravesical instillation of pirarubicin(THP) combined with IL-2 is effective for prevention of postoperatic recurrence of superficial bladder cancer with less side effect and easy to use,so it can be widely used in such patients.
    结论THP联合IL-2用于临床膀胱灌注预防浅表膀胱癌术后复发效果好,不良反应少,给药方便,值得临床推广应用。
 

首页上一页1下一页尾页 

 
CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社